Octalfa

Octalfa stands as a distinguished independent family enterprise with nearly three decades of dedication to innovation in healthcare and life sciences. Founded by Gilles Alberici, the group has established itself as a significant player in biotechnology, focusing on critical medical domains including pediatric medicine, cancer immunology, advanced diagnostics, and specialized materials development. Their entrepreneurial approach combines scientific expertise with strategic investment vision, creating a unique position in the European biotech investment landscape.

The investment portfolio of Octalfa reflects their deep commitment to transformative healthcare solutions. Their capital allocation strategy prioritizes companies developing breakthrough technologies with potential for substantial clinical impact. With investments spanning early-stage startups to more established biotech firms, Octalfa has cultivated a diverse ecosystem of portfolio companies working on next-generation therapeutics, diagnostic platforms, and medical technologies. Their investment approach typically combines financial support with strategic guidance, leveraging the family's extensive industry connections and scientific expertise to accelerate growth.

Beyond pure financial returns, Octalfa demonstrates a profound commitment to social responsibility through the Dominique & Tom Alberici Foundation and their dedicated endowment fund. Since 2008, these philanthropic initiatives have been fully integrated into the group's core strategy and governance structure. Their humanitarian efforts specifically target support for cancer patients and individuals with disabilities, with a special emphasis on pediatric care. These programs operate primarily in France and Madagascar, reflecting the group's international humanitarian vision while maintaining strong regional connections.

What distinguishes Octalfa in the investment landscape is their holistic approach to value creation. Rather than viewing their portfolio companies as mere financial assets, they foster an ecosystem where scientific innovation, business development, and social impact coexist harmoniously. This philosophy has enabled them to maintain long-term partnerships with researchers, healthcare institutions, and fellow investors across Europe. As the biotech sector continues evolving, Octalfa's combination of family-driven values with sophisticated investment strategies positions them uniquely to support the next generation of healthcare innovations while maintaining their commitment to improving patient outcomes worldwide.